Six documents to plan, execute, and document IQ/OQ/PQ validation that satisfies FDA investigators and ISO 13485 auditors — master plan, protocols, summary report, and revalidation checklist.
For QA managers, process engineers, and manufacturing leads at FDA-regulated device companies.
FDA QMSR 820.75 and ISO 13485 §7.5.6 require documented IQ/OQ/PQ validation for any process whose output cannot be fully verified by subsequent inspection and test — sterilization, welding, bonding, sealing, injection molding, and more.
The most common gaps: statistical sampling deficiencies, missing protocol-report linkage, and undefined revalidation triggers. This toolkit gives you every document needed to close those gaps before an investigator finds them.
From validation planning through execution, documentation, and ongoing monitoring.
The governing document FDA and MDSAP auditors request first. Covers validation scope, rationale, acceptance criteria approach, equipment list, validation schedule, and personnel qualification requirements. Ready to fill in and use as a controlled document.
Installation Qualification protocol with integrated report section. Covers equipment identification, utility requirements verification, calibration records, installation checklist, and IQ approval signature block. Formatted as a single controlled document.
Operational Qualification protocol with acceptance criteria, test methods, parameter range verification, and challenge testing. Includes statistical sampling guidance and worked examples for injection molding, sealing, and heat treatment processes.
Performance Qualification protocol covering production-scale conditions, batch sizes, sampling plans, and statistical analysis. Includes Cpk calculation worksheet, acceptance criteria guidance, and FDA-expected content for process capability demonstration.
Consolidated validation summary for management review and regulatory submissions. Integrates IQ/OQ/PQ findings, documents final acceptance, and provides the approval record FDA expects at the close of each validation lifecycle stage.
Decision tool for when revalidation is required: equipment changes, material changes, facility moves, process parameter shifts, and production volume changes. Includes QMSR change control integration and ISO 13485 §7.5.2 revalidation documentation requirements.
Statistical sampling deficiencies are cited in 61% of process validation 483s. Every PQ protocol includes sample size justification and acceptance criteria based on FDA expectations (Cpk ≥ 1.33).
FDA's Process Validation Guidance is the benchmark for device manufacturing. Every document maps to the three-stage lifecycle approach FDA expects — Stage 1 (Design of Process), Stage 2 (Process Qualification), Stage 3 (Continued Process Verification).
FDA 483s frequently cite protocols that exist without executed reports, or reports without approved protocols. Each IQ/OQ/PQ template combines protocol and report in a single controlled document — the format investigators expect.
A process validation consultant charges $8,000–$15,000 per validation engagement. This toolkit covers all six documents for $247 — one time, instant download.
We had three processes requiring validation before our ISO 13485 certification audit. These protocols got us through IQ/OQ/PQ on all three with zero observations. The statistical sampling guidance in the PQ template alone saved us weeks of back-and-forth with our notified body.
I've been through 11 FDA inspections over my career. The IQ/OQ/PQ protocol format in this toolkit is exactly what investigators expect — the right structure, the right content, the right level of statistical justification. I wish I'd had this 10 years ago.
Our process validation consultant quoted $24,000 for three equipment validations. We used this toolkit, did it in-house in three weeks, and our MDSAP auditor had zero findings on process validation. The Revalidation Trigger Checklist alone is worth more than the purchase price.
Any process where the output cannot be fully verified by subsequent inspection and test requires validation per QMSR 820.75. Common examples: sterilization, welding, bonding, sealing, injection molding, coating, and heat treatment. Under QMSR 820.75 and ISO 13485 §7.5.6, these processes require documented IQ/OQ/PQ with approved protocols, executed reports, and records demonstrating ongoing control.
FDA expects statistically justified sample sizes. The PQ protocol template includes sample size calculation guidance based on process capability targets (typically Cpk ≥ 1.33). For most processes, three consecutive batches at commercial scale with sampling plans justified by the criticality of the process characteristics being measured.
Changes to equipment, materials, process parameters, facility, or production environment that could affect product quality require revalidation evaluation. The Revalidation Trigger Checklist covers every QMSR and ISO 13485 required scenario with a documented decision tree for your change control process.
The IQ/OQ/PQ framework applies to all manufacturing processes including sterilization. Sterilization validation also requires compliance with ISO 11135 (EtO), ISO 11137 (radiation), or ISO 17665 (steam) — which have additional requirements beyond this toolkit. The master plan and protocol templates are designed to be adapted for process-specific requirements.
No. This is a practitioner reference toolkit developed from real device manufacturing experience. The templates and guidance reflect FDA expectations based on published guidance and enforcement patterns. Consult your regulatory counsel for formal compliance opinions.
RegWatchDaily covers FDA enforcement, QMSR updates, and ISO 13485 changes for device manufacturers.
Six documents. Instant download. FDA QMSR 820.75 + ISO 13485 §7.5.6.
✓ 7-Day Money-Back Guarantee · ✓ Instant Download